Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Atuliflapon (AZD5718) is a novel 5-Lipoxygenase Activating Protein(FLAP) inhibitor for Treatment of Coronary Artery Disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 112.00 | |
2 mg | In stock | $ 159.00 | |
5 mg | In stock | $ 239.00 | |
10 mg | In stock | $ 355.00 | |
25 mg | In stock | $ 590.00 | |
50 mg | In stock | $ 859.00 | |
100 mg | In stock | $ 1,180.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 263.00 |
Description | Atuliflapon (AZD5718) is a novel 5-Lipoxygenase Activating Protein(FLAP) inhibitor for Treatment of Coronary Artery Disease. |
Targets&IC50 | FLAP:2 nM (IC50) |
Synonyms | AZD5718 |
Molecular Weight | 446.5 |
Formula | C24H26N6O3 |
CAS No. | 2041075-86-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (55.99 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atuliflapon 2041075-86-7 Immunology/Inflammation FLAP Inhibitor inhibit AZD5718 artery disease Coronary 5-LO activating protein AZD-5718 AZD 5718 inhibitor